These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The life as a caregiver of a person affected by Chorea Huntington: multiple case study]. Winkler E; Ausserhofer D; Mantovan F Pflege Z; 2012 Oct; 65(10):608-11. PubMed ID: 23098031 [TBL] [Abstract][Full Text] [Related]
6. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia. Sitek EJ; Sołtan W; Wieczorek D; Schinwelski M; Robowski P; Reilmann R; Guzińska K; Harciarek M; Krysa W; Sławek J J Int Neuropsychol Soc; 2011 Sep; 17(5):788-95. PubMed ID: 21729402 [TBL] [Abstract][Full Text] [Related]
7. Involuntary movements in chorea-acanthocytosis: a comparison with Huntington's chorea. Shibasaki H; Sakai T; Nishimura H; Sato Y; Goto I; Kuroiwa Y Ann Neurol; 1982 Sep; 12(3):311-4. PubMed ID: 6215892 [No Abstract] [Full Text] [Related]
8. [A psychodynamic approach in counselling vulnerable persons for Chorea Huntington -- a case report]. Richartz ER; Frank C Psychiatr Prax; 2004 Jul; 31(5):255-8. PubMed ID: 15243876 [TBL] [Abstract][Full Text] [Related]
9. Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? Carlozzi NE; Schilling S; Kratz AL; Paulsen JS; Frank S; Stout JC Qual Life Res; 2018 Oct; 27(10):2541-2555. PubMed ID: 29909483 [TBL] [Abstract][Full Text] [Related]
10. Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians. Sherman CW; Iyer R; Abler V; Antonelli A; Carlozzi NE Neuropsychol Rehabil; 2020 Jul; 30(6):1150-1168. PubMed ID: 30849283 [TBL] [Abstract][Full Text] [Related]
11. Severity of cognitive impairment in juvenile and late-onset Huntington disease. Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775 [TBL] [Abstract][Full Text] [Related]
12. Social system responses to Huntington disease. Kessler S; Bloch M Fam Process; 1989 Mar; 28(1):59-68. PubMed ID: 2522897 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Kirkwood SC; Siemers E; Stout JC; Hodes ME; Conneally PM; Christian JC; Foroud T Arch Neurol; 1999 May; 56(5):563-8. PubMed ID: 10328251 [TBL] [Abstract][Full Text] [Related]
14. Progression of symptoms in the early and middle stages of Huntington disease. Kirkwood SC; Su JL; Conneally P; Foroud T Arch Neurol; 2001 Feb; 58(2):273-8. PubMed ID: 11176966 [TBL] [Abstract][Full Text] [Related]
15. [Self-awareness of deficits in Huntington's and Parkinson's disease]. Sitek EJ; Sławek J; Wieczorek D Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567 [TBL] [Abstract][Full Text] [Related]
16. [Huntington chorea. Clinical correlations and preliminary neuropsychological data]. Fragassi NA; Stanzione M; Angelini R; Di Maio L Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994 [TBL] [Abstract][Full Text] [Related]
17. Abnormal eye movements in three types of chorea. Attoni T; Beato R; Pinto S; Cardoso F Arq Neuropsiquiatr; 2016 Sep; 74(9):761-766. PubMed ID: 27706426 [TBL] [Abstract][Full Text] [Related]
18. Bradykinesia in early Huntington's disease. Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136 [TBL] [Abstract][Full Text] [Related]
19. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Fenney A; Jog MS; Duval C Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471 [TBL] [Abstract][Full Text] [Related]
20. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]